Court Cranks the Clock Back on Opposed Crankshaft Patent Refusal

The Madras High Court set aside the refusal of an opposed piston engine patent, citing insufficient analysis of inventive features. The case underscores the need for detailed examination of claim amendments and inventive step in Indian patent proceedings.

Read more about Court Cranks the Clock Back on Opposed Crankshaft Patent Refusal

‘Controller under an obligation to inform inventor’ says Madras High Court

The Madras High Court stressed that patent Controllers are obliged to provide detailed reasoning for refusals, enabling inventors to understand the grounds for rejection. The Court set aside two refusal orders and ordered fresh consideration, reinforcing the importance of transparency and due process in Indian patent law.

Read more about ‘Controller under an obligation to inform inventor’ says Madras High Court

Let’s see who gets the ‘Zee’! Prem Biyani vs Zee Entertainment

The Madras High Court remanded a trademark dispute involving Prem Biyani and Zee Entertainment, focusing on class distinctions and the status of well-known marks. The judgment highlights the need for careful, statutory evaluation of trademark applications across different classes.

Read more about Let’s see who gets the ‘Zee’! Prem Biyani vs Zee Entertainment

Patent examination should not kill the scientific temper of an inventor

The Madras High Court set aside the rejection of Industeel France’s patent application, stressing the need for fair and consistent patent examination. The judgment highlights the importance of protecting inventors’ scientific temper and ensuring time-bound decisions under Indian patent law.

Read more about Patent examination should not kill the scientific temper of an inventor

Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)

The Madras High Court clarified the interpretation of Section 3c regarding patent eligibility of monoclonal antibodies in India. The Court held that synthetic antibodies may be patentable if they demonstrate novelty or technical advancement.

Read more about Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)

Victory for Novozymes: Madras High Court Overrules Patent Office’s Refusal

The Madras High Court has reversed the Patent Office’s rejection of Novozymes’ patent for enzyme granules in animal feed, emphasizing the need for detailed reasoning in refusal orders. The decision clarifies the application of inventive step and Section 3d in Indian patent law.

Read more about Victory for Novozymes: Madras High Court Overrules Patent Office’s Refusal

Engineered non-living substances are not excluded under Section 3(c) of the Patents Act, 1970.

The Madras High Court held that Section 3c of the Patents Act, 1970 does not exclude engineered non-living substances from patent protection. The ruling clarifies the distinction between discovery and invention for biotechnology patents in India.

Read more about Engineered non-living substances are not excluded under Section 3(c) of the Patents Act, 1970.